Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127529 · ClinicalTrials.gov registry record
Ceprotin Treatment Registry
A clinical trial, sponsored by Baxalta now part of Shire.
- Completed
- Registry status
- 43
- Enrollment target
NCT01127529 is a clinical trial that has completed, run by Baxalta now part of Shire. The registered enrollment target is 43 participants.
The verdict
NCT01127529 has completed, sponsored by Baxalta now part of Shire.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The overall objective is to collect and assess data on the treatment, safety, and treatment outcomes of subjects prescribed, receiving and participating in the Ceprotin treatment registry.
Interventions
- BIOLOGICAL Protein C Concentrate (Human)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2010-06-23 |
| Est. Completion | 2015-06-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01127529
The ClinicalTrials.gov registry entry for NCT01127529 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxalta now part of Shire, which has 74 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Protein C Concentrate (Human) is the first listed.
NCT01127529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01127529 about?
NCT01127529 is a clinical study titled "Ceprotin Treatment Registry". The overall objective is to collect and assess data on the treatment, safety, and treatment outcomes of subjects prescribed, receiving and participating in the Ceprotin treatment registry.
What is the current status of trial NCT01127529?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2010-06-23. Estimated completion is 2015-06-22.
What interventions are being tested in trial NCT01127529?
The interventions under investigation include: Protein C Concentrate (Human) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01127529?
This trial is sponsored by Baxalta now part of Shire, which has 74 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.